Research Article
Volume 11 Issue 7 - 2022
Quality of Life Strategies for Patients with End-Stage Renal Failure
Prevyzi Evangelia*
RN, PhD©, MSc, Director of the Public Training Institute for Nursing Assistants, General Hospital of Piraeus “Tzaneio”, Greece
*Corresponding Author: Prevyzi Evangelia, RN, PhD©, MSc, Director of the Public Training Institute for Nursing Assistants, General Hospital of Piraeus “Tzaneio”, Greece.
Received: June 01, 2022; Published: June 30, 2022




Abstract

Introduction: The health-related quality of life of patients with end-stage renal failure is affected by: their physical and mental health, their functional status, their personal life and their social functionality. Renal insufficiency is defined as the irreversible loss of renal function. The gradual decline of renal function leads to a final stage of renal insufficiency, so it is necessary to treat the patient with renal function replacement therapy, by one of three methods: dialysis, peritoneal and transplantation.

Aim: The aim of the review was to highlight strategies for the quality of life of patients with end-stage renal disease.

Methodology: For the aim of this literature review, articles in English were searched in the international Pubmed database for the period 2010-2022, on the quality of life strategies of patients with end-stage renal failure. The abstracts of 50 articles were collected and from them 17 articles were selected whose full text was sufficient for the writing of the article.

Results and Discussion: Maintaining residual renal function is an important and favorable prognostic indicator of reduced morbidity, mortality and higher quality of life in both patients undergoing peritoneal dialysis and patients undergoing artificial kidney. The need to implement global strategies to achieve these goals is necessary through the economic and political planning of each state. Easy access to dialysis, financial support, the provision of specialized care, the adequacy of the medical staff, the possibility of transplantation are pillars of these strategies. To achieve these goals, the International Society of Nephrology established the Global Kidney Health Atlas to determine the global implementation of strategies for both kidney replacement therapy and the quality of life of these patients.

Conclusions: The quality of life strategies of patients with chronic kidney disease undergoing dialysis are related to: ethnicity, employment status, low income status, increased duration of dialysis, various socio-demographic factors, accessibility and availability of specialized health structures, the adequacy of medical staff. All of these global parameters need to be adjusted so that all CKD patients have immediate access to solutions to their problem.

Keywords: Dialysis; End Stage Renal Failure; Peritoneal Dialysis; Quality of Life

References

  1. Glover C., et al. “Understanding and assessing the impact of end-stage renal disease on quality of life: a systematic review of the content validity of self-administered instruments used to assess health-related quality of life in end-stage renal disease”. Patient 1 (2011): 19-30.
  2. Amini M., et al. “Hemodialysis adequacy and treatment in Iranian patients: a national multicenter study”. Iranian Journal of Kidney Diseases 2 (2011): 103-109.
  3. Theofilou P and Panagiotaki H. “Quality of Life in Patients with Chronic Renal Failure: Differences between the Early and Later Years of Current Treatment”. Nosileftiki 3 (2010): 295-304.
  4. Mazairac AH., et al. “Clinical performance targets and quality of life in hemodialysis patients”. Blood Purification 1-3 (2012): 73-79.
  5. Karkar A. “Modalities of hemodialysis: quality improvement”. Saudi Journal of Kidney Diseases and Transplantation 6 (2012): 1145-1161.
  6. Tian Li., et al. “Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients”. Journal of the American Society of Nephrology 6 (2019): 411-421.
  7. Aminu K., et al. “ISN North America and the Caribbean Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean”. Kidney International Supplements 2 (2021): e66-e76.
  8. Dearbhla M., et al. “ISN Western Europe Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe”. Kidney International Supplements 2 (2011): e106-e118.
  9. Dębska-Ślizień A., et al. “ISN Eastern and Central Europe Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe”. Kidney International Supplements 2 (2021): e24-e34.
  10. Luxia Z., et al. “ISN North and East Asia Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia”. Kidney International Supplements 2 (2011): e77-e85.
  11. Zakharova E., et al. “ISN Newly Independent States and Russia Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia”. Kidney International Supplements 2 (2021): e57-e65.
  12. Amouzegar Α., et al. “ISN Middle East Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East”. Kidney International Supplements 2 (2011): e47-e56.
  13. Wainstein Μ., et al. “ISN Latin America Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America”. Kidney International Supplements 2 (2021): e35-e46.
  14. Ethier I., et al. “ISN Oceania and South East Asia Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia”. Kidney International Supplements 2 (2011): e86-e96.
  15. Divyaveer S., et al. “ISN South Asia Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia”. Kidney International Supplements 2 (2011): e97-e105.
  16. Bharati J., et al. “The Global Kidney Health Atlas: Burden and Opportunities to Improve Kidney Health Worldwide”. Annals of Nutrition and Metabolism 1 (2020): 25-30.
  17. Kam Tao Li., et al. “For the World Kidney Day Steering Committee”. Journal of the American Society of Nephrology4 (2020): 255-262.
Citation: Prevyzi Evangelia. “Quality of Life Strategies for Patients with End-Stage Renal Failure”. EC Psychology and Psychiatry 11.7 (2022): 47-53.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.